☰

Hannah A. Hathaway, Ph.D. - Publications

Affiliations: 
2014 Pharmacology Georgetown University, Washington, DC 
Area:
Neuropharmacology, glutamate receptors
Tree Info Grants Similar researchers PubMed Report error

9 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Dahl KD, Almeida AR, Hathaway HA, Bourne J, Brown TL, Finseth LT, Wood TL, Macklin WB. mTORC2 loss in oligodendrocyte progenitor cells results in regional hypomyelination in the central nervous system. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 36460463 DOI: 10.1523/JNEUROSCI.0010-22.2022  0.706
2021 Kohnke S, Buller S, Nuzzaci D, Ridley K, Lam B, Pivonkova H, Bentsen MA, Alonge KM, Zhao C, Tadross J, Holmqvist S, Shimizo T, Hathaway H, Li H, Macklin W, et al. Nutritional regulation of oligodendrocyte differentiation regulates perineuronal net remodeling in the median eminence. Cell Reports. 36: 109362. PMID 34260928 DOI: 10.1016/j.celrep.2021.109362  0.47
2015 Gelb T, Pshenichkin S, Hathaway HA, Grajkowska E, Dalley CB, Wolfe BB, Wroblewski JT. Atypical signaling of metabotropic glutamate receptor 1 in human melanoma cells. Biochemical Pharmacology. 98: 182-9. PMID 26291396 DOI: 10.1016/J.Bcp.2015.08.091  0.856
2015 Hathaway HA, Pshenichkin S, Grajkowska E, Gelb T, Emery AC, Wolfe BB, Wroblewski JT. Pharmacological characterization of mGlu1 receptors in cerebellar granule cells reveals biased agonism. Neuropharmacology. 93: 199-208. PMID 25700650 DOI: 10.1016/J.Neuropharm.2015.02.007  0.805
2015 Gelb T, Pshenichkin S, Rodriguez OC, Hathaway HA, Grajkowska E, DiRaddo JO, Wroblewska B, Yasuda RP, Albanese C, Wolfe BB, Wroblewski JT. Metabotropic glutamate receptor 1 acts as a dependence receptor creating a requirement for glutamate to sustain the viability and growth of human melanomas. Oncogene. 34: 2711-20. PMID 25065592 DOI: 10.1038/Onc.2014.231  0.773
2015 Gelb T, Pshenichkin S, Hathaway HA, Grajkowska E, Wolfe BB, Wroblewski JT. Abstract A15: mGlu1 Receptors and downstream signal transduction proteins as therapeutic targets for the treatment of metastatic melanoma Cancer Research. 75. DOI: 10.1158/1538-7445.Mel2014-A15  0.849
2014 Gelb T, Hathaway HA, Wroblewski JT. Triple threat treatment: Exploiting the dependence receptor properties of metabotropic glutamate receptor 1 against melanoma. Molecular & Cellular Oncology. 1: e969163. PMID 27308372 DOI: 10.4161/23723548.2014.969163  0.851
2014 DiRaddo JO, Miller EJ, Hathaway HA, Grajkowska E, Wroblewska B, Wolfe BB, Liotta DC, Wroblewski JT. A real-time method for measuring cAMP production modulated by Gαi/o-coupled metabotropic glutamate receptors. The Journal of Pharmacology and Experimental Therapeutics. 349: 373-82. PMID 24659805 DOI: 10.1124/Jpet.113.211532  0.784
2012 Emery AC, DiRaddo JO, Miller E, Hathaway HA, Pshenichkin S, Takoudjou GR, Grajkowska E, Yasuda RP, Wolfe BB, Wroblewski JT. Ligand bias at metabotropic glutamate 1a receptors: molecular determinants that distinguish β-arrestin-mediated from G protein-mediated signaling. Molecular Pharmacology. 82: 291-301. PMID 22584219 DOI: 10.1124/Mol.112.078444  0.637
Show low-probability matches.